Published in Am J Public Health on July 17, 2014
Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology (2015) 1.44
Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System. Public Health Rep (2016) 0.75
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med (2006) 18.63
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med (1999) 16.35
Natural history of chronic hepatitis C. Hepatology (2002) 7.70
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med (2012) 7.56
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep (2012) 6.91
Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int (2011) 3.36
Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology (2013) 2.62
Epidemiology of hepatocellular carcinoma in USA. Hepatol Res (2007) 2.56
Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health (2004) 2.27
Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol (2003) 2.18
Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study. Clin Infect Dis (2012) 1.79
Liver and intestine transplantation in the United States 1998-2007. Am J Transplant (2009) 1.73
Evolving epidemiology of hepatitis C virus in the United States. Clin Infect Dis (2012) 1.60
Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States. J Urban Health (2008) 1.17
Screening for HCV infection in jails. JAMA (2012) 1.11
Prevalence and correlates of Hepatitis C among injection drug users: The significance of duration of use, incarceration and race/ethnicity. J Drug Issues (2009) 0.81
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med (2002) 11.38
Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. J Rheumatol (2012) 2.43
Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg (2008) 2.31
Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant (2004) 1.33
Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg (2006) 1.11
Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents. J Vasc Interv Radiol (2005) 1.06
Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol (2004) 0.97
Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis. J Virol (2014) 0.94
Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial. Liver Transpl (2004) 0.93
Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway. PLoS One (2012) 0.91
Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients. Liver Transpl (2002) 0.90
Recurrent hepatic epithelioid hemangioendothelioma after orthotopic liver transplantation. Hepatology (2014) 0.88
Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis. Liver Transpl (2011) 0.86
Successful orthotopic liver transplantation in an adult patient with sickle cell disease and review of the literature. Hematol Rep (2013) 0.85
Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation. Transplantation (2011) 0.84
Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis. PLoS One (2013) 0.84
Severe Clostridium difficile colitis: the role of intracolonic vancomycin? Am J Med (2002) 0.83
Exploring interprofessional education in the family medicine clerkship: a CERA study. Fam Med (2014) 0.81
Reduced uptake of FDOPA PET in end-stage liver disease with elevated manganese levels. Arch Neurol (2012) 0.81
Disseminated histoplasmosis in a liver transplant recipient. Liver Transpl (2006) 0.80
The psychiatric diagnosis of alcohol abuse and the medical diagnosis of alcoholic related liver disease: effects on liver transplant survival. J Clin Psychol Med Settings (2010) 0.80
Intensive interferon therapy does not increase virological response rates in African Americans with chronic hepatitis C. Dig Dis Sci (2003) 0.78
Treatment of hepatocellular carcinoma after transplantation and human rights. Hepatology (2007) 0.77
Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient. Transplantation (2011) 0.77
Parenchymal alterations in cirrhotic livers in patients with hepatopulmonary syndrome or portopulmonary hypertension. Liver Transpl (2013) 0.77
Once weekly fluconazole for antifungal prophylaxis post-liver transplantation. HPB (Oxford) (2012) 0.76
Liver transplantation for hepatocellular carcinoma. Curr Gastroenterol Rep (2015) 0.76
Biopsy of suspicious liver nodules: does it change management? Clin Gastroenterol Hepatol (2006) 0.76
Liver volume in the cirrhotic patient: does size matter? Dig Dis Sci (2014) 0.75
Live donor liver transplantation: is it better than waiting? Gastroenterology (2007) 0.75
Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival. Arch Surg (2008) 0.75
Management of hepatitis C in the setting of liver transplantation. Clin Liver Dis (2006) 0.75
The "slip". Virtual Mentor (2005) 0.75
Science Reinforcing Mission. How Can Our Communities Move Ahead After Ferguson? Health Prog (2016) 0.75
Correctional health care: a forgotten ministry of the church. Health Prog (2014) 0.75
Serial measurements of bone density at the lumbar spine do not predict fracture risk after liver transplantation. Liver Transpl (2003) 0.75
Image of the month. Portal hypertension as a result of extramedullary hematopoiesis caused by idiopathic myelofibrosis. Clin Gastroenterol Hepatol (2008) 0.75